Cargando…
Integrated multiomic analysis and high‐throughput screening reveal potential gene targets and synergetic drug combinations for osteosarcoma therapy
Although great advances have been made over the past decades, therapeutics for osteosarcoma are quite limited. We performed long‐read RNA sequencing and tandem mass tag (TMT)‐based quantitative proteome on osteosarcoma and the adjacent normal tissues, next‐generation sequencing (NGS) on paired osteo...
Autores principales: | Zhang, Wenchao, Qi, Lin, Liu, Zhongyue, He, Shasha, Wang, Cheng‐zhi, Wu, Ying, Han, Lianbin, Liu, Zhenxin, Fu, Zheng, Tu, Chao, Li, Zhihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338795/ https://www.ncbi.nlm.nih.gov/pubmed/37457661 http://dx.doi.org/10.1002/mco2.317 |
Ejemplares similares
-
A Novel Glutamine Metabolism-Related Gene Signature in Prognostic Prediction of Osteosarcoma
por: Wan, Lu, et al.
Publicado: (2022) -
MTHFR Polymorphism Is Associated With Severe Methotrexate-Induced Toxicity in Osteosarcoma Treatment
por: Zhang, Wenchao, et al.
Publicado: (2021) -
Identification of cuproptosis-related lncRNA prognostic signature for osteosarcoma
por: Liu, Binfeng, et al.
Publicado: (2022) -
Molecular characterization of immunogenic cell death indicates prognosis and tumor microenvironment infiltration in osteosarcoma
por: Liu, Zhongyue, et al.
Publicado: (2022) -
A novel necroptosis-related lncRNAs signature effectively predicts the prognosis for osteosarcoma and is associated with immunity
por: Liu, Binfeng, et al.
Publicado: (2022)